Fingerprint
Dive into the research topics of 'A phase 2 study of the PARP inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase 2 study of the PARP inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancer
Michael J. Pishvaian, Rebecca S. Slack, Wei Jiang, A. Ruth He, Jimmy J. Hwang, Amy Hankin, Karen Dorsch-Vogel, Divyesh Kukadiya, Louis M. Weiner, John L. Marshall, Jonathan R. Brody
Research output: Contribution to journal › Article › peer-review
39
Scopus
citations